{"entity":{"type":"insider","cik":"0001769914","url":"/insider/0001769914","json_url":"/insider/0001769914.json","name":"Ragan Paula","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":40,"n_filings":37,"first":"2020-03-03","last":"2025-01-27","span_basis":"filed_date"},"name_variants":[{"name":"Ragan Paula","source":"filing","n_filings":37,"first_seen":"2020-03-03","last_seen":"2025-01-27"}],"transactions":[{"id":4969615,"accession":"0001628280-25-002709","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001628280-25-002709","line_url":"/filing/0001628280-25-002709#line-2","is_derivative":false,"issuer_cik":"0001501697","issuer_name":"X4 Pharmaceuticals, Inc","issuer_ticker":"XFOR","issuer_name_source":null,"issuer_url":"/issuer/0001501697","owner_cik":"0001769914","owner_name":"Ragan Paula","owner_display_name":"Ragan Paula","owner_url":"/insider/0001769914","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":76473.0,"shares_display":"76,473","price_per_share":0.454,"price_display":"0.45","price_state":"stated","total_value":34718.742,"total_display":"34,718.74","total_whole":"34,719","shares_owned_after":1087386.0,"shares_owned_after_display":"1,087,386","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-24","filed_date":"2025-01-27","scope":"insider"},{"id":2225817,"accession":"0001628280-24-048467","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-24-048467","line_url":"/filing/0001628280-24-048467#line-1","is_derivative":false,"issuer_cik":"0001501697","issuer_name":"X4 Pharmaceuticals, Inc","issuer_ticker":"XFOR","issuer_name_source":null,"issuer_url":"/issuer/0001501697","owner_cik":"0001769914","owner_name":"Ragan Paula","owner_display_name":"Ragan Paula","owner_url":"/insider/0001769914","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":31897.0,"shares_display":"31,897","price_per_share":0.3945,"price_display":"0.39","price_state":"stated","total_value":12583.3665,"total_display":"12,583.37","total_whole":"12,583","shares_owned_after":993919.0,"shares_owned_after_display":"993,919","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-15","filed_date":"2024-11-19","scope":"insider"},{"id":2049083,"accession":"0001628280-24-042941","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-24-042941","line_url":"/filing/0001628280-24-042941#line-1","is_derivative":false,"issuer_cik":"0001501697","issuer_name":"X4 Pharmaceuticals, Inc","issuer_ticker":"XFOR","issuer_name_source":null,"issuer_url":"/issuer/0001501697","owner_cik":"0001769914","owner_name":"Ragan Paula","owner_display_name":"Ragan Paula","owner_url":"/insider/0001769914","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":31897.0,"shares_display":"31,897","price_per_share":0.562,"price_display":"0.56","price_state":"stated","total_value":17926.114,"total_display":"17,926.11","total_whole":"17,926","shares_owned_after":1025816.0,"shares_owned_after_display":"1,025,816","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-15","filed_date":"2024-10-16","scope":"insider"},{"id":2405005,"accession":"0001628280-24-042543","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001628280-24-042543","line_url":"/filing/0001628280-24-042543#line-2","is_derivative":false,"issuer_cik":"0001501697","issuer_name":"X4 Pharmaceuticals, Inc","issuer_ticker":"XFOR","issuer_name_source":null,"issuer_url":"/issuer/0001501697","owner_cik":"0001769914","owner_name":"Ragan Paula","owner_display_name":"Ragan Paula","owner_url":"/insider/0001769914","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":239436.0,"shares_display":"239,436","price_per_share":0.5493,"price_display":"0.55","price_state":"stated","total_value":131522.1948,"total_display":"131,522.19","total_whole":"131,522","shares_owned_after":1057713.0,"shares_owned_after_display":"1,057,713","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-07","filed_date":"2024-10-08","scope":"insider"},{"id":2921900,"accession":"0001628280-24-010280","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-24-010280","line_url":"/filing/0001628280-24-010280#line-1","is_derivative":false,"issuer_cik":"0001501697","issuer_name":"X4 Pharmaceuticals, Inc","issuer_ticker":"XFOR","issuer_name_source":null,"issuer_url":"/issuer/0001501697","owner_cik":"0001769914","owner_name":"Ragan Paula","owner_display_name":"Ragan Paula","owner_url":"/insider/0001769914","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":49678.0,"shares_display":"49,678","price_per_share":0.8828,"price_display":"0.88","price_state":"stated","total_value":43855.7384,"total_display":"43,855.74","total_whole":"43,856","shares_owned_after":765068.0,"shares_owned_after_display":"765,068","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-11","filed_date":"2024-03-11","scope":"insider"},{"id":2992426,"accession":"0001628280-24-004266","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-24-004266","line_url":"/filing/0001628280-24-004266#line-1","is_derivative":false,"issuer_cik":"0001501697","issuer_name":"X4 Pharmaceuticals, Inc","issuer_ticker":"XFOR","issuer_name_source":null,"issuer_url":"/issuer/0001501697","owner_cik":"0001769914","owner_name":"Ragan Paula","owner_display_name":"Ragan Paula","owner_url":"/insider/0001769914","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21695.0,"shares_display":"21,695","price_per_share":1.0091,"price_display":"1.01","price_state":"stated","total_value":21892.4245,"total_display":"21,892.42","total_whole":"21,892","shares_owned_after":814746.0,"shares_owned_after_display":"814,746","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-12","filed_date":"2024-02-12","scope":"insider"},{"id":7881598,"accession":"0001628280-23-036796","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001628280-23-036796","line_url":"/filing/0001628280-23-036796#line-2","is_derivative":false,"issuer_cik":"0001501697","issuer_name":"X4 Pharmaceuticals, Inc","issuer_ticker":"XFOR","issuer_name_source":null,"issuer_url":"/issuer/0001501697","owner_cik":"0001769914","owner_name":"Ragan Paula","owner_display_name":"Ragan Paula","owner_url":"/insider/0001769914","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":39906.0,"shares_display":"39,906","price_per_share":0.9,"price_display":"0.90","price_state":"stated","total_value":35915.4,"total_display":"35,915.40","total_whole":"35,915","shares_owned_after":836441.0,"shares_owned_after_display":"836,441","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-03","filed_date":"2023-11-03","scope":"insider"},{"id":7881595,"accession":"0001628280-23-036796","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-23-036796","line_url":"/filing/0001628280-23-036796#line-1","is_derivative":false,"issuer_cik":"0001501697","issuer_name":"X4 Pharmaceuticals, Inc","issuer_ticker":"XFOR","issuer_name_source":null,"issuer_url":"/issuer/0001501697","owner_cik":"0001769914","owner_name":"Ragan Paula","owner_display_name":"Ragan Paula","owner_url":"/insider/0001769914","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":199531.0,"shares_display":"199,531","price_per_share":0.73,"price_display":"0.73","price_state":"stated","total_value":145657.63,"total_display":"145,657.63","total_whole":"145,658","shares_owned_after":876347.0,"shares_owned_after_display":"876,347","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-01","filed_date":"2023-11-03","scope":"insider"},{"id":8047506,"accession":"0001628280-23-023440","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-23-023440","line_url":"/filing/0001628280-23-023440#line-1","is_derivative":false,"issuer_cik":"0001501697","issuer_name":"X4 Pharmaceuticals, Inc","issuer_ticker":"XFOR","issuer_name_source":null,"issuer_url":"/issuer/0001501697","owner_cik":"0001769914","owner_name":"Ragan Paula","owner_display_name":"Ragan Paula","owner_url":"/insider/0001769914","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6724.0,"shares_display":"6,724","price_per_share":1.92,"price_display":"1.92","price_state":"stated","total_value":12910.08,"total_display":"12,910.08","total_whole":"12,910","shares_owned_after":543797.0,"shares_owned_after_display":"543,797","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-23","filed_date":"2023-06-26","scope":"insider"},{"id":8047467,"accession":"0001628280-23-022469","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-23-022469","line_url":"/filing/0001628280-23-022469#line-1","is_derivative":false,"issuer_cik":"0001501697","issuer_name":"X4 Pharmaceuticals, Inc","issuer_ticker":"XFOR","issuer_name_source":null,"issuer_url":"/issuer/0001501697","owner_cik":"0001769914","owner_name":"Ragan Paula","owner_display_name":"Ragan Paula","owner_url":"/insider/0001769914","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6724.0,"shares_display":"6,724","price_per_share":2.23,"price_display":"2.23","price_state":"stated","total_value":14994.52,"total_display":"14,994.52","total_whole":"14,995","shares_owned_after":550521.0,"shares_owned_after_display":"550,521","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-15","filed_date":"2023-06-16","scope":"insider"},{"id":8007693,"accession":"0001628280-23-020355","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-23-020355","line_url":"/filing/0001628280-23-020355#line-1","is_derivative":false,"issuer_cik":"0001501697","issuer_name":"X4 Pharmaceuticals, Inc","issuer_ticker":"XFOR","issuer_name_source":null,"issuer_url":"/issuer/0001501697","owner_cik":"0001769914","owner_name":"Ragan Paula","owner_display_name":"Ragan Paula","owner_url":"/insider/0001769914","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6292.0,"shares_display":"6,292","price_per_share":1.95,"price_display":"1.95","price_state":"stated","total_value":12269.4,"total_display":"12,269.40","total_whole":"12,269","shares_owned_after":557245.0,"shares_owned_after_display":"557,245","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-31","filed_date":"2023-05-31","scope":"insider"},{"id":8755824,"accession":"0001628280-23-007720","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-23-007720","line_url":"/filing/0001628280-23-007720#line-1","is_derivative":false,"issuer_cik":"0001501697","issuer_name":"X4 Pharmaceuticals, Inc","issuer_ticker":"XFOR","issuer_name_source":null,"issuer_url":"/issuer/0001501697","owner_cik":"0001769914","owner_name":"Ragan Paula","owner_display_name":"Ragan Paula","owner_url":"/insider/0001769914","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":49678.0,"shares_display":"49,678","price_per_share":0.84,"price_display":"0.84","price_state":"stated","total_value":41729.52,"total_display":"41,729.52","total_whole":"41,730","shares_owned_after":563537.0,"shares_owned_after_display":"563,537","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-10","filed_date":"2023-03-13","scope":"insider"},{"id":8237857,"accession":"0001628280-23-003755","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-23-003755","line_url":"/filing/0001628280-23-003755#line-1","is_derivative":false,"issuer_cik":"0001501697","issuer_name":"X4 Pharmaceuticals, Inc","issuer_ticker":"XFOR","issuer_name_source":null,"issuer_url":"/issuer/0001501697","owner_cik":"0001769914","owner_name":"Ragan Paula","owner_display_name":"Ragan Paula","owner_url":"/insider/0001769914","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21695.0,"shares_display":"21,695","price_per_share":0.93,"price_display":"0.93","price_state":"stated","total_value":20176.35,"total_display":"20,176.35","total_whole":"20,176","shares_owned_after":613215.0,"shares_owned_after_display":"613,215","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-13","filed_date":"2023-02-15","scope":"insider"},{"id":6103553,"accession":"0001628280-22-023324","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-22-023324","line_url":"/filing/0001628280-22-023324#line-1","is_derivative":false,"issuer_cik":"0001501697","issuer_name":"X4 Pharmaceuticals, Inc","issuer_ticker":"XFOR","issuer_name_source":null,"issuer_url":"/issuer/0001501697","owner_cik":"0001769914","owner_name":"Ragan Paula","owner_display_name":"Ragan Paula","owner_url":"/insider/0001769914","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13448.0,"shares_display":"13,448","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":634910.0,"shares_owned_after_display":"634,910","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-17","filed_date":"2022-08-19","scope":"insider"},{"id":6907898,"accession":"0001628280-22-018043","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-22-018043","line_url":"/filing/0001628280-22-018043#line-1","is_derivative":false,"issuer_cik":"0001501697","issuer_name":"X4 Pharmaceuticals, Inc","issuer_ticker":"XFOR","issuer_name_source":null,"issuer_url":"/issuer/0001501697","owner_cik":"0001769914","owner_name":"Ragan Paula","owner_display_name":"Ragan Paula","owner_url":"/insider/0001769914","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6724.0,"shares_display":"6,724","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":648358.0,"shares_owned_after_display":"648,358","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-24","filed_date":"2022-06-27","scope":"insider"},{"id":6377732,"accession":"0001628280-22-017436","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-22-017436","line_url":"/filing/0001628280-22-017436#line-1","is_derivative":false,"issuer_cik":"0001501697","issuer_name":"X4 Pharmaceuticals, Inc","issuer_ticker":"XFOR","issuer_name_source":null,"issuer_url":"/issuer/0001501697","owner_cik":"0001769914","owner_name":"Ragan Paula","owner_display_name":"Ragan Paula","owner_url":"/insider/0001769914","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6724.0,"shares_display":"6,724","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":655082.0,"shares_owned_after_display":"655,082","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-16","filed_date":"2022-06-17","scope":"insider"},{"id":6870555,"accession":"0001628280-22-016336","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-22-016336","line_url":"/filing/0001628280-22-016336#line-1","is_derivative":false,"issuer_cik":"0001501697","issuer_name":"X4 Pharmaceuticals, Inc","issuer_ticker":"XFOR","issuer_name_source":null,"issuer_url":"/issuer/0001501697","owner_cik":"0001769914","owner_name":"Ragan Paula","owner_display_name":"Ragan Paula","owner_url":"/insider/0001769914","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6292.0,"shares_display":"6,292","price_per_share":1.21,"price_display":"1.21","price_state":"stated","total_value":7613.32,"total_display":"7,613.32","total_whole":"7,613","shares_owned_after":661806.0,"shares_owned_after_display":"661,806","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-03","filed_date":"2022-06-06","scope":"insider"},{"id":6580746,"accession":"0001628280-22-002506","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-22-002506","line_url":"/filing/0001628280-22-002506#line-1","is_derivative":false,"issuer_cik":"0001501697","issuer_name":"X4 Pharmaceuticals, Inc","issuer_ticker":"XFOR","issuer_name_source":null,"issuer_url":"/issuer/0001501697","owner_cik":"0001769914","owner_name":"Ragan Paula","owner_display_name":"Ragan Paula","owner_url":"/insider/0001769914","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21695.0,"shares_display":"21,695","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":447309.0,"shares_owned_after_display":"447,309","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-11","filed_date":"2022-02-14","scope":"insider"},{"id":4739139,"accession":"0001628280-21-017331","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-21-017331","line_url":"/filing/0001628280-21-017331#line-1","is_derivative":false,"issuer_cik":"0001501697","issuer_name":"X4 Pharmaceuticals, Inc","issuer_ticker":"XFOR","issuer_name_source":null,"issuer_url":"/issuer/0001501697","owner_cik":"0001769914","owner_name":"Ragan Paula","owner_display_name":"Ragan Paula","owner_url":"/insider/0001769914","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13448.0,"shares_display":"13,448","price_per_share":5.1,"price_display":"5.10","price_state":"stated","total_value":68584.8,"total_display":"68,584.80","total_whole":"68,585","shares_owned_after":469004.0,"shares_owned_after_display":"469,004","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-17","filed_date":"2021-08-19","scope":"insider"},{"id":4578126,"accession":"0001628280-21-013959","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-21-013959","line_url":"/filing/0001628280-21-013959#line-1","is_derivative":false,"issuer_cik":"0001501697","issuer_name":"X4 Pharmaceuticals, Inc","issuer_ticker":"XFOR","issuer_name_source":null,"issuer_url":"/issuer/0001501697","owner_cik":"0001769914","owner_name":"Ragan Paula","owner_display_name":"Ragan Paula","owner_url":"/insider/0001769914","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13448.0,"shares_display":"13,448","price_per_share":5.78,"price_display":"5.78","price_state":"stated","total_value":77729.44,"total_display":"77,729.44","total_whole":"77,729","shares_owned_after":482452.0,"shares_owned_after_display":"482,452","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-15","filed_date":"2021-07-16","scope":"insider"},{"id":4799320,"accession":"0001628280-21-011531","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-21-011531","line_url":"/filing/0001628280-21-011531#line-1","is_derivative":false,"issuer_cik":"0001501697","issuer_name":"X4 Pharmaceuticals, Inc","issuer_ticker":"XFOR","issuer_name_source":null,"issuer_url":"/issuer/0001501697","owner_cik":"0001769914","owner_name":"Ragan Paula","owner_display_name":"Ragan Paula","owner_url":"/insider/0001769914","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2400.0,"shares_display":"2,400","price_per_share":9.5,"price_display":"9.50","price_state":"stated","total_value":22800.0,"total_display":"22,800.00","total_whole":"22,800","shares_owned_after":406248.0,"shares_owned_after_display":"406,248","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-02","filed_date":"2021-06-02","scope":"insider"},{"id":5123516,"accession":"0001628280-21-011502","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-21-011502","line_url":"/filing/0001628280-21-011502#line-1","is_derivative":false,"issuer_cik":"0001501697","issuer_name":"X4 Pharmaceuticals, Inc","issuer_ticker":"XFOR","issuer_name_source":null,"issuer_url":"/issuer/0001501697","owner_cik":"0001769914","owner_name":"Ragan Paula","owner_display_name":"Ragan Paula","owner_url":"/insider/0001769914","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4104.0,"shares_display":"4,104","price_per_share":9.41,"price_display":"9.41","price_state":"stated","total_value":38618.64,"total_display":"38,618.64","total_whole":"38,619","shares_owned_after":408648.0,"shares_owned_after_display":"408,648","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-01","filed_date":"2021-06-02","scope":"insider"},{"id":4243606,"accession":"0001628280-21-008873","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-21-008873","line_url":"/filing/0001628280-21-008873#line-1","is_derivative":false,"issuer_cik":"0001501697","issuer_name":"X4 Pharmaceuticals, Inc","issuer_ticker":"XFOR","issuer_name_source":null,"issuer_url":"/issuer/0001501697","owner_cik":"0001769914","owner_name":"Ragan Paula","owner_display_name":"Ragan Paula","owner_url":"/insider/0001769914","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2400.0,"shares_display":"2,400","price_per_share":8.33,"price_display":"8.33","price_state":"stated","total_value":19992.0,"total_display":"19,992.00","total_whole":"19,992","shares_owned_after":412752.0,"shares_owned_after_display":"412,752","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-03","filed_date":"2021-05-04","scope":"insider"},{"id":5504541,"accession":"0001628280-21-006624","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-21-006624","line_url":"/filing/0001628280-21-006624#line-1","is_derivative":false,"issuer_cik":"0001501697","issuer_name":"X4 Pharmaceuticals, Inc","issuer_ticker":"XFOR","issuer_name_source":null,"issuer_url":"/issuer/0001501697","owner_cik":"0001769914","owner_name":"Ragan Paula","owner_display_name":"Ragan Paula","owner_url":"/insider/0001769914","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2400.0,"shares_display":"2,400","price_per_share":9.17,"price_display":"9.17","price_state":"stated","total_value":22008.0,"total_display":"22,008.00","total_whole":"22,008","shares_owned_after":415152.0,"shares_owned_after_display":"415,152","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-05","filed_date":"2021-04-07","scope":"insider"},{"id":4392067,"accession":"0001628280-21-003760","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-21-003760","line_url":"/filing/0001628280-21-003760#line-1","is_derivative":false,"issuer_cik":"0001501697","issuer_name":"X4 Pharmaceuticals, Inc","issuer_ticker":"XFOR","issuer_name_source":null,"issuer_url":"/issuer/0001501697","owner_cik":"0001769914","owner_name":"Ragan Paula","owner_display_name":"Ragan Paula","owner_url":"/insider/0001769914","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2400.0,"shares_display":"2,400","price_per_share":9.74,"price_display":"9.74","price_state":"stated","total_value":23376.0,"total_display":"23,376.00","total_whole":"23,376","shares_owned_after":272923.0,"shares_owned_after_display":"272,923","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-02","filed_date":"2021-03-02","scope":"insider"},{"id":5419091,"accession":"0001628280-21-001402","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-21-001402","line_url":"/filing/0001628280-21-001402#line-1","is_derivative":false,"issuer_cik":"0001501697","issuer_name":"X4 Pharmaceuticals, Inc","issuer_ticker":"XFOR","issuer_name_source":null,"issuer_url":"/issuer/0001501697","owner_cik":"0001769914","owner_name":"Ragan Paula","owner_display_name":"Ragan Paula","owner_url":"/insider/0001769914","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2400.0,"shares_display":"2,400","price_per_share":7.88,"price_display":"7.88","price_state":"stated","total_value":18912.0,"total_display":"18,912.00","total_whole":"18,912","shares_owned_after":275323.0,"shares_owned_after_display":"275,323","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-02","filed_date":"2021-02-03","scope":"insider"},{"id":5532798,"accession":"0001628280-21-000148","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-21-000148","line_url":"/filing/0001628280-21-000148#line-1","is_derivative":false,"issuer_cik":"0001501697","issuer_name":"X4 Pharmaceuticals, Inc","issuer_ticker":"XFOR","issuer_name_source":null,"issuer_url":"/issuer/0001501697","owner_cik":"0001769914","owner_name":"Ragan Paula","owner_display_name":"Ragan Paula","owner_url":"/insider/0001769914","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2400.0,"shares_display":"2,400","price_per_share":7.0,"price_display":"7.00","price_state":"stated","total_value":16800.0,"total_display":"16,800.00","total_whole":"16,800","shares_owned_after":277723.0,"shares_owned_after_display":"277,723","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-05","filed_date":"2021-01-06","scope":"insider"},{"id":2350883,"accession":"0001628280-20-017775","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-20-017775","line_url":"/filing/0001628280-20-017775#line-1","is_derivative":false,"issuer_cik":"0001501697","issuer_name":"X4 Pharmaceuticals, Inc","issuer_ticker":"XFOR","issuer_name_source":null,"issuer_url":"/issuer/0001501697","owner_cik":"0001769914","owner_name":"Ragan Paula","owner_display_name":"Ragan Paula","owner_url":"/insider/0001769914","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4800.0,"shares_display":"4,800","price_per_share":7.0,"price_display":"7.00","price_state":"stated","total_value":33600.0,"total_display":"33,600.00","total_whole":"33,600","shares_owned_after":280123.0,"shares_owned_after_display":"280,123","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-23","filed_date":"2020-12-28","scope":"insider"},{"id":2717408,"accession":"0001628280-20-014331","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-20-014331","line_url":"/filing/0001628280-20-014331#line-1","is_derivative":false,"issuer_cik":"0001501697","issuer_name":"X4 Pharmaceuticals, Inc","issuer_ticker":"XFOR","issuer_name_source":null,"issuer_url":"/issuer/0001501697","owner_cik":"0001769914","owner_name":"Ragan Paula","owner_display_name":"Ragan Paula","owner_url":"/insider/0001769914","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1797.0,"shares_display":"1,797","price_per_share":7.0,"price_display":"7.00","price_state":"stated","total_value":12579.0,"total_display":"12,579.00","total_whole":"12,579","shares_owned_after":284923.0,"shares_owned_after_display":"284,923","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-10-05","filed_date":"2020-10-06","scope":"insider"},{"id":3163316,"accession":"0001628280-20-014296","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-20-014296","line_url":"/filing/0001628280-20-014296#line-1","is_derivative":false,"issuer_cik":"0001501697","issuer_name":"X4 Pharmaceuticals, Inc","issuer_ticker":"XFOR","issuer_name_source":null,"issuer_url":"/issuer/0001501697","owner_cik":"0001769914","owner_name":"Ragan Paula","owner_display_name":"Ragan Paula","owner_url":"/insider/0001769914","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":603.0,"shares_display":"603","price_per_share":7.0,"price_display":"7.00","price_state":"stated","total_value":4221.0,"total_display":"4,221.00","total_whole":"4,221","shares_owned_after":286720.0,"shares_owned_after_display":"286,720","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-10-02","filed_date":"2020-10-05","scope":"insider"},{"id":2717360,"accession":"0001628280-20-013422","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-20-013422","line_url":"/filing/0001628280-20-013422#line-1","is_derivative":false,"issuer_cik":"0001501697","issuer_name":"X4 Pharmaceuticals, Inc","issuer_ticker":"XFOR","issuer_name_source":null,"issuer_url":"/issuer/0001501697","owner_cik":"0001769914","owner_name":"Ragan Paula","owner_display_name":"Ragan Paula","owner_url":"/insider/0001769914","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8840.0,"shares_display":"8,840","price_per_share":8.04,"price_display":"8.04","price_state":"stated","total_value":71073.6,"total_display":"71,073.60","total_whole":"71,074","shares_owned_after":287323.0,"shares_owned_after_display":"287,323","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-09","filed_date":"2020-09-10","scope":"insider"},{"id":2765656,"accession":"0001628280-20-013295","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-20-013295","line_url":"/filing/0001628280-20-013295#line-1","is_derivative":false,"issuer_cik":"0001501697","issuer_name":"X4 Pharmaceuticals, Inc","issuer_ticker":"XFOR","issuer_name_source":null,"issuer_url":"/issuer/0001501697","owner_cik":"0001769914","owner_name":"Ragan Paula","owner_display_name":"Ragan Paula","owner_url":"/insider/0001769914","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2400.0,"shares_display":"2,400","price_per_share":7.99,"price_display":"7.99","price_state":"stated","total_value":19176.0,"total_display":"19,176.00","total_whole":"19,176","shares_owned_after":296163.0,"shares_owned_after_display":"296,163","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-02","filed_date":"2020-09-03","scope":"insider"},{"id":3062839,"accession":"0001628280-20-011642","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-20-011642","line_url":"/filing/0001628280-20-011642#line-1","is_derivative":false,"issuer_cik":"0001501697","issuer_name":"X4 Pharmaceuticals, Inc","issuer_ticker":"XFOR","issuer_name_source":null,"issuer_url":"/issuer/0001501697","owner_cik":"0001769914","owner_name":"Ragan Paula","owner_display_name":"Ragan Paula","owner_url":"/insider/0001769914","role":"Officer (President and CEO)","role_mark":"O","role_mark_label":"Officer (President and CEO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2400.0,"shares_display":"2,400","price_per_share":7.45,"price_display":"7.45","price_state":"stated","total_value":17880.0,"total_display":"17,880.00","total_whole":"17,880","shares_owned_after":208912.0,"shares_owned_after_display":"208,912","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-03","filed_date":"2020-08-04","scope":"insider"},{"id":3301546,"accession":"0001628280-20-010212","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-20-010212","line_url":"/filing/0001628280-20-010212#line-1","is_derivative":false,"issuer_cik":"0001501697","issuer_name":"X4 Pharmaceuticals, Inc","issuer_ticker":"XFOR","issuer_name_source":null,"issuer_url":"/issuer/0001501697","owner_cik":"0001769914","owner_name":"Ragan Paula","owner_display_name":"Ragan Paula","owner_url":"/insider/0001769914","role":"Officer (President and CEO)","role_mark":"O","role_mark_label":"Officer (President and CEO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2400.0,"shares_display":"2,400","price_per_share":9.05,"price_display":"9.05","price_state":"stated","total_value":21720.0,"total_display":"21,720.00","total_whole":"21,720","shares_owned_after":211312.0,"shares_owned_after_display":"211,312","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-02","filed_date":"2020-07-06","scope":"insider"},{"id":2828195,"accession":"0001628280-20-008920","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001628280-20-008920","line_url":"/filing/0001628280-20-008920#line-3","is_derivative":false,"issuer_cik":"0001501697","issuer_name":"X4 Pharmaceuticals, Inc","issuer_ticker":"XFOR","issuer_name_source":null,"issuer_url":"/issuer/0001501697","owner_cik":"0001769914","owner_name":"Ragan Paula","owner_display_name":"Ragan Paula","owner_url":"/insider/0001769914","role":"Officer (President and CEO)","role_mark":"O","role_mark_label":"Officer (President and CEO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9707.0,"shares_display":"9,707","price_per_share":8.88,"price_display":"8.88","price_state":"stated","total_value":86198.16,"total_display":"86,198.16","total_whole":"86,198","shares_owned_after":213712.0,"shares_owned_after_display":"213,712","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-03","filed_date":"2020-06-03","scope":"insider"},{"id":2828190,"accession":"0001628280-20-008920","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001628280-20-008920","line_url":"/filing/0001628280-20-008920#line-2","is_derivative":false,"issuer_cik":"0001501697","issuer_name":"X4 Pharmaceuticals, Inc","issuer_ticker":"XFOR","issuer_name_source":null,"issuer_url":"/issuer/0001501697","owner_cik":"0001769914","owner_name":"Ragan Paula","owner_display_name":"Ragan Paula","owner_url":"/insider/0001769914","role":"Officer (President and CEO)","role_mark":"O","role_mark_label":"Officer (President and CEO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2400.0,"shares_display":"2,400","price_per_share":8.65,"price_display":"8.65","price_state":"stated","total_value":20760.0,"total_display":"20,760.00","total_whole":"20,760","shares_owned_after":223419.0,"shares_owned_after_display":"223,419","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-02","filed_date":"2020-06-03","scope":"insider"},{"id":2828185,"accession":"0001628280-20-008920","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-20-008920","line_url":"/filing/0001628280-20-008920#line-1","is_derivative":false,"issuer_cik":"0001501697","issuer_name":"X4 Pharmaceuticals, Inc","issuer_ticker":"XFOR","issuer_name_source":null,"issuer_url":"/issuer/0001501697","owner_cik":"0001769914","owner_name":"Ragan Paula","owner_display_name":"Ragan Paula","owner_url":"/insider/0001769914","role":"Officer (President and CEO)","role_mark":"O","role_mark_label":"Officer (President and CEO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4275.0,"shares_display":"4,275","price_per_share":8.63,"price_display":"8.63","price_state":"stated","total_value":36893.25,"total_display":"36,893.25","total_whole":"36,893","shares_owned_after":225819.0,"shares_owned_after_display":"225,819","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-01","filed_date":"2020-06-03","scope":"insider"},{"id":2043040,"accession":"0001628280-20-006483","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-20-006483","line_url":"/filing/0001628280-20-006483#line-1","is_derivative":false,"issuer_cik":"0001501697","issuer_name":"X4 Pharmaceuticals, Inc","issuer_ticker":"XFOR","issuer_name_source":null,"issuer_url":"/issuer/0001501697","owner_cik":"0001769914","owner_name":"Ragan Paula","owner_display_name":"Ragan Paula","owner_url":"/insider/0001769914","role":"Officer (President and CEO)","role_mark":"O","role_mark_label":"Officer (President and CEO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2400.0,"shares_display":"2,400","price_per_share":8.92,"price_display":"8.92","price_state":"stated","total_value":21408.0,"total_display":"21,408.00","total_whole":"21,408","shares_owned_after":230094.0,"shares_owned_after_display":"230,094","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-04","filed_date":"2020-05-05","scope":"insider"},{"id":3200574,"accession":"0001628280-20-004587","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-20-004587","line_url":"/filing/0001628280-20-004587#line-1","is_derivative":false,"issuer_cik":"0001501697","issuer_name":"X4 Pharmaceuticals, Inc","issuer_ticker":"XFOR","issuer_name_source":null,"issuer_url":"/issuer/0001501697","owner_cik":"0001769914","owner_name":"Ragan Paula","owner_display_name":"Ragan Paula","owner_url":"/insider/0001769914","role":"Officer (President and CEO)","role_mark":"O","role_mark_label":"Officer (President and CEO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2400.0,"shares_display":"2,400","price_per_share":8.4,"price_display":"8.40","price_state":"stated","total_value":20160.0,"total_display":"20,160.00","total_whole":"20,160","shares_owned_after":232494.0,"shares_owned_after_display":"232,494","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-04-02","filed_date":"2020-04-03","scope":"insider"},{"id":2717126,"accession":"0001628280-20-002798","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-20-002798","line_url":"/filing/0001628280-20-002798#line-1","is_derivative":false,"issuer_cik":"0001501697","issuer_name":"X4 Pharmaceuticals, Inc","issuer_ticker":"XFOR","issuer_name_source":null,"issuer_url":"/issuer/0001501697","owner_cik":"0001769914","owner_name":"Ragan Paula","owner_display_name":"Ragan Paula","owner_url":"/insider/0001769914","role":"Officer (President and CEO)","role_mark":"O","role_mark_label":"Officer (President and CEO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2400.0,"shares_display":"2,400","price_per_share":10.64,"price_display":"10.64","price_state":"stated","total_value":25536.0,"total_display":"25,536.00","total_whole":"25,536","shares_owned_after":234894.0,"shares_owned_after_display":"234,894","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-02","filed_date":"2020-03-03","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":40,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":40,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":40},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001501697","name":"X4 Pharmaceuticals, Inc","url":"/issuer/0001501697","role":"Director, Officer (President and CEO)","n_filings":37,"first_seen":"2020-03-03","last_seen":"2025-01-27"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001769914","retrieved_at":"2026-08-25T19:49:08+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}